Of enteral nutrition

Convincing evidence on the efficacy of enteral nutrition in the prevention of stress-related mucosal damage not... [Pg.89]

Vitamin K content of enteral nutrition formulas may affect pharmacological activity. Monitor and titrate dose to maintain therapeutic international normalized ratio (INR)... [Pg.141]

Compare clinical efficacy, complications, and costs of enteral nutrition (EN) versus parenteral nutrition (PN). [Pg.1511]

Gastrointestinal complications are the most common complications of enteral nutrition (EN), limiting the amount of feeding that patients receive. [Pg.1511]

Reduced bioavailability in the presence of enteral nutrition Possible binding of phenytoin to calcium caseinates or protein hydrolysates in enteral feeding... [Pg.662]

Lochs, II., Steinhardt, H., KJaus Wentz, B., Zeitz, M., Vogelsang, H., Sommer, H., Fleig, W., Bauer, P, Schirrmeister, J., and Malchow, H. (1991). Comparison of enteral nutrition and drug treatment in active Crohn s disease. Cast men terolof 101, 881-886-... [Pg.154]

Paling A, Girbes ARJ. Esophageal obstruction an unusual complication of enteral nutrition. Care Crit 111 2000 16 224-5. [Pg.1221]

What is the blenderized group of enteral nutritional support therapy preparations ... [Pg.125]

Name three complications of enteral nutritional support therapy. [Pg.125]

Three complications of enteral nutritional support therapy are dehydration, aspiration, and diarrhea. [Pg.125]

Records of enteric nutrition, peripheral parenteral nutrition, and central parenteral nutrition. [Pg.782]

MacLaren R, Jarvis CL, Eish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother 2001 35 1614-1623. [Pg.648]

While most drug therapy has yet to show benefit in patients with ARF, certain nutritional interventions may be useful. Pre-existing nutrition status has been shown to be a strong predictor of outcomes in patients with ARF. The use of enteral nutrition in patients with ARF in ICUs has been associated with an improvement in outcomes. Parenteral nutrition did not show the same benefit and some have questioned whether parenteral nutrition should ever be used in this population. ... [Pg.794]

Mattox TW, Brown RO, Boucher BA, et al. Use of fibronectin and somatomedin-C as markers of enteral nutrition support in traumatized patients using a modified amino acid formula. JPEN J Parenter Enteral Nutt 1988 12 592-596. [Pg.2576]

Intractable diarrhea of infancy infants younger than 3 months who have persistent diarrhea for more than 2 weeks with three or more stool cultures negative for enteropathogens, who have failed a trial of enteral nutrition support,... [Pg.2593]

Kudsk KA. Clinical applications of enteral nutrition. Nutt Clin Pract 1994 9 165-171. [Pg.2633]

Heyland DK, Drover JW, Dkaliwal R, Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill Role of small bowel feeding. JPEN J Parenter Enteral Nutr 2002 26(6 Suppl) S51-S55. [Pg.2633]

In a prospective cohort study in 319 children, the use of enteral nutrition (mostly vitamin K supplemented formula, and some vitamin K supplemented tube feeds) was associated with a higher dose of warfarin to achieve a target INR (0.28 versus 0.16 mg/kg) and similarly a higher dose of warfarin was needed to maintain the INR (0.26 versus 0.11 mg/kg). ... [Pg.407]

Parr MD, Record KE, Griffith GL, Zeok JV, Todd EP. Effect of enteral nutrition on warfarin therapy. ClinPharm (1982) 1, 274-6. [Pg.408]

In a prospective cohort study including 24 infants, the incidence and risk factors of parenteral nutrition-associated liver disease (PNALD) was determined. Eight infants developed PNALD. The concluded that the duration of enteral starvation, gastrointestinal surgery, duration of enteral nutrition, maximum caloric and carbohydrate intakes were significant risks of PNALD in newborn infants [lob ll. In a retrospective review of the safety and efficacy of PN among 105 paediatric patients with bum injuries (>30% total-body sxuface area), no respiratory or blood infections were observed with the use of parenteral nutrition, and the overall mortality rate was 4% [107 ]. [Pg.517]

Mancl EE, Muzevich KM. Tolerability and safety of enteral nutrition in critically iU patients receiving intravenous vasopressor therapy. JPEN J Parenter Enter Nutr September 2013 37(5) 641-51. [Pg.526]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...